Antiproliferative effects of antiestrogens and inhibitors of growth factor receptor signaling on endometrial cancer cells
PubMed ID
20651347
Abstract
In patients with advanced estrogen-dependent type I endometrial cancer (EC), pharmacological treatment with progestins or antiestrogens is recommended, but primary and secondary resistance are common. The aim of our study was to investigate single-agent and dual-agent therapeutic strategies in estrogen receptor-positive human EC cells.
Date Issued
2010
Publication Type
Article
Language(s)
en
Author(s)
Block, Martin | |
Fister, Stefanie | |
Emons, Günter | |
Seeber, Sandrine | |
Gründker, Carsten |
Additional Credits
Journal
Anticancer research
Publisher
International Inst. of Anticancer Research
ISSN
0250-7005
Access(Rights)
metadata.only